Product Description: Mitumomab is an anti-idiotypic mouse IgG2b monoclonal antibody that mimics the ganglioside GD3. Mitumomab can be used for the research of small-cell lung carcinoma[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Antonio Rossi, et al. New Targeted Therapies and Small-Cell Lung Cancer. Clinical Lung Cancer